Found Weight Loss Review 2026: How It Works, Cost, Verdict

Found's Approach: Medication Plus Behavior Change

Found was founded in 2019 with a philosophy that weight loss requires more than just medication, it requires a comprehensive approach that addresses the behavioral, psychological, and environmental factors that contribute to weight gain. This "whole person" approach sets Found apart from many telehealth platforms that focus primarily on prescribing and delivering GLP-1 medications.

At its core, Found's model pairs prescription weight loss medication with dedicated health coaching, a community of fellow patients, and educational content designed to help patients build sustainable habits. The company positions itself not just as a medication delivery platform but as a weight loss program that happens to include medication as one component of a multi-pronged strategy. This approach is grounded in real science, meta-analyses consistently demonstrate that intensive lifestyle interventions combined with pharmacotherapy produce greater and more sustained weight loss than either approach alone.

Found's medication options are not limited to GLP-1 receptor agonists. Their providers evaluate each patient's health profile and may recommend GLP-1 medications like semaglutide or tirzepatide, or they may recommend other pharmacological approaches such as metformin, bupropion-naltrexone (Contrave), topiramate, or other medications depending on the patient's clinical situation, insurance coverage, and treatment goals. This medication flexibility is a genuine advantage for patients whose clinical profiles may not be ideal for GLP-1 therapy or who want to explore less expensive medication options first.

The trade-off with Found's comprehensive approach is cost and complexity. Patients who specifically want affordable, streamlined access to compounded GLP-1 medications without the additional coaching layer may find that the bundled model adds cost without adding the value they are personally seeking. This is an important distinction, Found's coaching is genuinely valuable for many patients, but it is not what every patient needs or wants.

Found's Coaching Model: How It Works

The coaching component is central to Found's value proposition and worth examining in detail. After enrollment, patients are matched with a dedicated health coach who provides regular check-ins, accountability, and personalized guidance on nutrition, exercise, sleep, stress management, and other lifestyle factors that influence weight management outcomes.

Coaching interactions typically happen through the Found app via messaging, with the frequency and depth varying by plan tier. The coaches are trained in behavior change methodologies and work with patients to identify and overcome specific obstacles, whether that is emotional eating patterns, difficulty with meal planning, sedentary work environments, or the psychological challenges that often accompany significant weight loss. This kind of structured support can be transformative for patients who have struggled with weight management on their own.

Found also provides community features where patients can connect with others on similar journeys. The peer support element, sharing experiences, challenges, and successes, adds a social dimension to the weight loss process that pure medication-delivery platforms do not typically offer. Community engagement is a well-documented factor in behavior change maintenance, and Found has invested in building this aspect of their platform.

The honest assessment of Found's coaching model is that it works well for a specific patient profile: someone who benefits from external accountability, wants structured behavioral support, and is willing to pay a premium for a comprehensive program. For patients who are self-motivated, have existing support systems, or primarily need affordable medication access, the coaching component may represent an added cost that does not match their personal needs. Neither approach is right or wrong, it depends entirely on the individual patient.

Found Pricing: Breaking Down the Costs

Found's pricing has more moving parts than a single flat rate, but the medication is not billed on top. For compounded semaglutide and tirzepatide, one plan price per 28-day cycle covers clinical care, membership, the medication, and shipping, at the same price at every dose. What changes the price is the plan length you choose and whether you use Found's cash-pay or insurance track.

On cash pay, compounded semaglutide costs $169 per cycle on a 12-month plan, $219 on 6 months, $249 on 3 months, or $179 for the first month and then $289 month to month. Compounded tirzepatide costs $239, $289, and $309 on those terms, or $219 for the first month and then $359 month to month. Insurance plans cost less per cycle, from $99 for semaglutide and $179 for tirzepatide on a 12-month plan, and still include the compounded medication; what insurance pays for is the required video visits, each billed at your copay, which Found says is typically around $30. Branded GLP-1 medications are the one case where Found bills the medication separately from the plan price. Prices were checked on joinfound.com on 28 September 2026.

For comparison, Trimi charges $99 per month for compounded semaglutide and $125 per month for compounded tirzepatide on the annual plan (a 12-month commitment), covering the provider consultation, medication, and ongoing clinical support. Both models are all-inclusive; the difference is the price level, because Found's plan also pays for its broader behavioral program. The result is that patients seeking specifically GLP-1 therapy often find more affordable options through focused platforms than through comprehensive programs that bundle additional services.

It is important to evaluate Found's pricing in terms of what you are actually receiving. If you will actively use the coaching and community features, the additional cost may be justified by the behavioral support. If you are primarily interested in affordable GLP-1 medication access with solid clinical oversight, a focused platform will likely provide better value for your specific needs. The key is honest self-assessment about which services you will actually use.

Medication Options on Found

One of Found's strengths is the breadth of their medication formulary. Unlike platforms that offer only GLP-1 medications, Found's providers can prescribe from a wider range of weight loss pharmacotherapies based on each patient's clinical profile. This flexibility is a genuine advantage for patients who may not be candidates for GLP-1 therapy or who want to explore other medication pathways first.

Found's medication options typically include GLP-1 receptor agonists (semaglutide and potentially tirzepatide depending on availability), metformin (which has modest weight loss effects and can help with insulin resistance), bupropion-naltrexone combinations (which target appetite regulation through different neurological pathways), and other medications that the provider may recommend based on the patient's specific metabolic profile and health history.

For patients specifically seeking GLP-1 therapy, however, Found's multi-medication approach can sometimes feel less focused than platforms built specifically around GLP-1 access. Found's providers may recommend non-GLP-1 medications that they consider more appropriate for a particular patient's situation, which is clinically sound but may not align with patients who already know they want GLP-1 therapy and have a clear treatment preference.

Trimi's approach is more targeted: the platform exists specifically to provide affordable access to compounded semaglutide and tirzepatide with providers who specialize in these medications. For patients who know they want GLP-1 therapy, this focused approach eliminates ambiguity and ensures that the entire care experience is optimized around GLP-1 prescribing, dosing, and management. For more about safe access to compounded formulations, see our guide on compounded semaglutide safety.

Pros and Cons of Found Weight Loss

Found: Strengths

Found: Limitations

Found vs. Trimi: Who Is Each Platform Best For?

The choice between Found and Trimi comes down to what kind of weight loss experience you are looking for and how you define value in a healthcare relationship.

Found is likely the better fit if you value a comprehensive, coached weight loss program and are willing to pay more for structured behavioral support. If you are unsure whether GLP-1 therapy is right for you and want a provider to evaluate you for multiple medication options, Found's broad formulary is an advantage. If you have struggled with weight loss in the past and believe that coaching and community support would help you stay on track, Found's model is designed exactly for that need.

Trimi is likely the better fit if you already know you want GLP-1 therapy and want the most affordable and streamlined path to compounded semaglutide or tirzepatide. If you are self-motivated and do not feel you need external coaching to adhere to your treatment, Trimi eliminates the cost of services you would not use. If you want providers who specialize specifically in GLP-1 prescribing and management, Trimi's focused model delivers depth of expertise in that specific area. Trimi's transparent pricing also makes it easy to budget for long-term treatment.

There is no wrong choice between these platforms, they serve different patient needs authentically. The key is matching the platform to your actual needs rather than paying for features you will not use or skipping support that would genuinely help you succeed. For more options and an overview of costs across the GLP-1 landscape, review our guide on the cost of semaglutide treatment.